| 1. |
2025
Lin EP,Hsu CY,Mishra S,Griffiths EA,Segal BH,Hwang C,Singh SRK, Balanchivadze N, Jani C, Mariano MG, Bhatt PS, Vieira K, Yu PP, Oligino EJ, Wise-Draper T, Ferrara EK, McKay RR, Nonato TK, Labaki C, Saad E, Saliby RM, Morgans AK, Nohria A, Puc M, Accordino MK, Bodin BE, Nanchal R, Singh H, Berg S, Mavromatis B, McManus HD, Halabi S, Choueiri TK, Warner JL, Shyr Y, COVID-19 and Cancer Consortium..
Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infection
. Lancet Reg Health Am
.2025
|
|
| 2. |
2024
Huang BT,Lai WY,Yeh CL,Tseng YT,Peck K,Yang PC, Lin EP.
AptBCis1, an aptamer-cisplatin conjugate, is effective in lung cancer leptomeningeal carcinomatosis
. ACS Nano
.2024
|
|
| 3. |
2022
Emily Pei-Ying Lin,Chih-Yuan Hsu,Lynne Berry,Paul Bunn,Yu Shyr.
Analysis of Cancer Survival Associated With Immune Checkpoint Inhibitors After Statistical Adjustment: A Systematic Review and Meta-analyses
. JAMA Netw Open
.2022
|
|
| 4. |
2022
Emily Pei-Ying Lin,Chih-Yuan Hsu,Jeng-Fong Chiou,Lynne Berry,Leora Horn,Paul Bunn, James Chih-Hsin Yang, Pan-Chyr Yang, Alex A Adjei, Yu Shyr.
Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors (ICI): Cox-TEL Adjustment and Meta-analyses of PD-L1 Expression and ICI Survival Benefit
. J Thorac Oncol
.2022
|
|
| 5. |
2022
Emily Pei-Ying Lin,Li-Ching Huang,Jennifer Whisenant,Sally York,Travis Osterman,Jennifer Lewis, Wade Iams, Emily Skotte, Amanda Cass, Chih-Yuan Hsu, Yu Shyr, Leora Horn.
Associations of influenza vaccination with severity of immune-related adverse events in patients with advanced thoracic cancers on immune checkpoint inhibitors
. ERJ Open Research
.2022
|
|
| 6. |
2021
Emily Pei-Ying Lin,Bo-Tsang Huang,Wei-Yun Lai,Yi-Ting Tseng,Shuenn-Chen Yang,Hao-Cheng Kuo, Pan-Chyr Yang.
PINK1-mediated inhibition of EGFR dimerization and activation impedes EGFR-driven lung tumorigenesis
. Cancer Research
.2021
;(81):1745-1757
|
|
| 7. |
2021
Hsu, Chih-Yuan,Lin, Emily Pei-Ying,Shyr, Yu.
Development and Evaluation of a Method to Correct Misinterpretation of Clinical Trial Results with Long-term Survival
. JAMA oncology
.2021
|
|
| 8. |
2020
Wang, Mai,Lin, Emily Pei-Ying,Huang, Li-Ching,Li, Chung-Yi,Shyr, Yu,Lai, Chao-Han.
Mortality of Cardiovascular Events in Patients With COPD and Preceding Hospitalization for Acute Exacerbation
. Chest
.2020
;(158):973-985
|
|
| 9. |
2020
Satya Das,Kristen K Ciombor,Sigurdis Haraldsdottir,Yoanna Pumpalova,Ibrahim H Sahin,G Pineda, Yu Shyr, Emily Pei-Ying Lin, Chih-Yuan Hsu, Shih-Kai Chu, Laura W Goff, Dana B Cardin, Mehmet A Bilen, George A Fisher, Christina Wu, Jordan Berlin.
Immune-Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration-Approved Indications for Immunotherapy
. Oncologist
.2020
;(25):669-679
|
|
| 10. |
2019
Wei-Yun Lai,Jen-Wei Wang,Bo-Tsang Huang,Emily Pei-Ying Lin,Pan-Chyr Yang.
A novel TNF-α-targeting aptamer for TNF-α-mediated acute lung injury and acute liver failure
. Theranostics
.2019
;(9):1741-1751
|
|
| 11. |
2018
Lin Emily Pei-Ying,Hsiao Tzu-Hung,Lu Jo-yang,Wong Siao-Han,Lu Tzu-Pin,Konan Peck, Takashi Takahashi, Pan-Chyr Yang.
Translating gene signatures into a pathologic feature: Tumor necrosis predicts disease relapse in operable and stage I lung adenocarcinoma
. JCO Precision Oncology
.2018
;(2)
|
|
| 12. |
2018
Lin Emily Pei-Ying,Lin Ching-Heng,Yang Ching-Yao,Lu Tzu-Pin,Chang Shih-Ni,Tzu-Hung Hsiao, Bo-Tsang Huang, Chong-Jen Yu, K. Arnold Chan, Pan-Chyr Yang.
Population-based cohort study reveals distinct associations between female lung cancer and breast cancer in Taiwan
. JCO clinical cancer informatics
.2018
|
|
| 13. |
2017
Huang Bo-Tsang,Lai Wei-Yun,Chang Yi-Chung,Wang Jen-Wei,Yeh Shauh-Der,Emily Pei-Ying Lin, Pan-Chyr Yang.
A CTLA-4 Antagonizing DNA Aptamer with Antitumor Effect
. Molecular Therapy - Nucleic Acids
.2017
;(8):520-528
|
|
| 14. |
2017
Pei-Ying Lin,Hsuan-Yu Chen ,Sung-Liang Yu ,Pan-Chyr Yang .
Turning diversity toward precision
. Journal of the National Cancer Institute
.2017
;(109)
|
|